Literature DB >> 10077011

Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.

M Y Su1, Z Wang, P M Carpenter, X Lao, A Mühler, O Nalcioglu.   

Abstract

A carcinogen (N-ethyl-N-nitrosourea)-induced animal tumor model was established to grow malignant and benign breast tumors. In each tumor the pharmacokinetic characteristics were measured by using three contrast agents, gadolinium-diethylene-triamine-pentaacetic acid (Gd-DTPA; <1 kD), Gadomer-17 (35 kD), and albumin-Gd-DTPA (70-90 kD). Infiltrating ductal carcinomas (IDC) with low, medium, and high Scarf-Bloom-Richardson grades and fibroadenomas (FA) were analyzed. We found that Gd-DTPA could differentiate between FA and malignant tumors, but not between malignant tumors of low and high grades. In contrast, the intermediate size agent Gadomer-17 could differentiate between high-grade and low-grade IDC, but not between low-grade IDC and FA due to their similar enhancement patterns (despite their different origins). The largest agent, albumin-Gd-DTPA, was capable of differentiating both, but the low contrast-to-noise ratio was its major technical concern. The results in this breast tumor model suggest that macromolecular agents provide useful information for differential diagnosis among IDCs of various grades, but they do not provide superior information than Gd-DTPA for differential diagnosis between IDC and FA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077011     DOI: 10.1002/(sici)1522-2586(199902)9:2<177::aid-jmri5>3.0.co;2-8

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  13 in total

Review 1.  Applications of magnetic resonance in model systems: tumor biology and physiology.

Authors:  R J Gillies; Z M Bhujwalla; J Evelhoch; M Garwood; M Neeman; S P Robinson; C H Sotak; B Van Der Sanden
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation.

Authors:  Anda Preda; Viktor Novikov; Martina Möglich; Eugenia Floyd; Karl Turetschek; David M Shames; Timothy P L Roberts; Claire Corot; Wayne O Carter; Robert C Brasch
Journal:  Eur Radiol       Date:  2005-07-13       Impact factor: 5.315

Review 3.  Promise and progress for functional and molecular imaging of response to targeted therapies.

Authors:  Renu M Stephen; Robert J Gillies
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

4.  Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice.

Authors:  Xueming Wu; Yi Feng; Eun-Kee Jeong; Lyska Emerson; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2009-07-14       Impact factor: 4.200

5.  Tumor microvasculature: endothelial leakiness and endothelial pore size distribution in a breast cancer model.

Authors:  E E Uzgiris
Journal:  Breast Cancer (Auckl)       Date:  2008-06-06

6.  Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI.

Authors:  Kyle M Jones; Mark D Pagel; Julio Cárdenas-Rodríguez
Journal:  Magn Reson Imaging       Date:  2017-11-15       Impact factor: 2.546

7.  Simultaneous in vivo dynamic magnetic resonance-diffuse optical tomography for small animal imaging.

Authors:  Mehmet Burcin Unlu; Yuting Lin; Ozlem Birgul; Orhan Nalcioglu; Gultekin Gulsen
Journal:  J Biomed Opt       Date:  2008 Nov-Dec       Impact factor: 3.170

8.  Characterization of tumor vascular permeability using natural dextrans and CEST MRI.

Authors:  Yuguo Li; Yuan Qiao; Hanwei Chen; Renyuan Bai; Verena Staedtke; Zheng Han; Jiadi Xu; Kannie W Y Chan; Nirbhay Yadav; Jeff W M Bulte; Shibin Zhou; Peter C M van Zijl; Guanshu Liu
Journal:  Magn Reson Med       Date:  2017-11-28       Impact factor: 4.668

9.  Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.

Authors:  Yi Feng; Eun-Kee Jeong; Aaron M Mohs; Lyska Emerson; Zheng-Rong Lu
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

10.  Evaluation of tumor angiogenesis with a second-generation US contrast medium in a rat breast tumor model.

Authors:  Eun Young Ko; Sang Hoon Lee; Hak Hee Kim; Sung Moon Kim; Myung Jin Shin; Namkug Kim; Gyungyub Gong
Journal:  Korean J Radiol       Date:  2008 May-Jun       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.